— Know what they know.
Not Investment Advice

LNSR NASDAQ

LENSAR, Inc.
1W: +2.1% 1M: +9.4% 3M: -49.1% YTD: -48.8% 1Y: -57.4% 3Y: +157.6% 5Y: -25.5%
$6.09
+0.14 (+2.35%)
 
Weekly Expected Move ±8.4%
$5 $5 $6 $6 $6
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 60 · $73.7M mcap · 9M float · 1.37% daily turnover · Short 58% of daily vol

Cash Flow Trends

Operating Cash Flow
-$2M +76.4% ▲
Capital Expenditures
$156K +33.9% ▲
5Y CAGR: -40.5%
Free Cash Flow
-$2M +75.4% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$4M -173.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$20M-$20M-$20M-$14M-$31M
Depreciation & Amort.$3M$3M$3M$4M$4M
Stock-Based Comp.$9M$7M$7M$6M$3M
Change in Working Capital-$6M-$42K-$6M-$8M-$3M
Other Non-Cash Items$505K$517K$618K$3M$26M
Operating Cash Flow-$14M-$9M-$15M-$10M-$2M
— Investing Activities —
Capital Expenditures-$366K-$354K-$115K-$236K-$156K
Acquisitions (Net)$40K$0$0$0$0
Investment Purchases$0$0$0-$4M-$10M
Investment Sales$0$0$0$0$8M
Other Investing$0$0$0$0$0
Investing Cash Flow-$326K-$354K-$115K-$4M-$2M
— Financing Activities —
Net Debt Issuance$12M$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid-$2M$0$0$0$0
Other Financing$0$0-$2M$6M$20K
Financing Cash Flow$50M$361K-$2M$20M$78K
Net Change in Cash$36M-$9M-$17M$6M-$4M
Cash End of Period$41M$32M$15M$21M$16M
Free Cash Flow-$14M-$9M-$15M-$10M-$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms